| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Former EVP, CFO, &Director | EVP &CFO +1 more
3 companies
Weaver Gregory L is a Chief Financial Officer at Altimmune, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 2 sells.
Estimated insider holdings value: $106K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | ALT Altimmune, Inc. | Chief Financial Officer | Buy | 5,000 | $3.54 | $17,700.00 | +21.7% | - | - | |
| Mar 13, 2025 | ALT Altimmune, Inc. | Chief Financial Officer | Buy | 10,000 | $5.20 | $51,996.00 | New | +25.8% | -32.7% | |
| Nov 15, 2023 | ATOS Atossa Therapeutics, Inc. | Former EVP, CFO, &Director | Sell | 50,000 | $0.65 | $32,500.00 | -99.9% | +48.3% | +109.4% | |
| Jun 20, 2023 | ATOS Atossa Therapeutics, Inc. | EVP &CFO | Buy | 50,000 | $0.97 | $48,500.00 | +90,909% | -16.8% | +16.1% | |
| Jul 2, 2021 | ATOS Atossa Therapeutics, Inc. | Director | Sale+OE | 107,497 | $5.58 | $599,833.26 | -100% | -39.3% | -81.2% | |
| Jun 22, 2021 | ATAI Atai Beckley N.V. | Chief Financial Officer | Buy | 4,666 | $15.00 | $69,990.00 | New | -16.8% | -81.4% |